A breakthrough cancer drug around since 2017 has finally been given the go-ahead the SA Health Products Regulatory Authority has approved Keytruda for the treatment of bladder and lung cancer. The regulatory approval follows the review of studies and clinical-trial data. Oncologist Devan Moodley, from Wits Donald Gordon Medical Centre shares more on this.
